Financial insights of SDGR

MyFinsight

For the quarter ending 2026-03-31, SDGR made $58,587K in revenue. -$60,026K in net income. Net profit margin of -102.46%.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total revenues	58,587	87,235	54,324	54,759
Software Products And Services	10,863	14,791*	11,111	13,029
Drug Discovery	16,310	15,151*	15,174	15,572
Contribution	1,867	-	-	-
Total cost of revenues	29,040	29,942	26,285	28,601
Gross profit	29,547	57,293	28,039	26,158
Research and development	43,824	41,399	42,757	43,138
Sales and marketing	11,603	10,338	9,524	10,734
General and administrative (includes related party expense of 165 and 109, respectively)	22,914	22,713	21,705	25,189
Total operating expenses	78,341	74,450	73,986	79,061
Loss from operations	-48,794	-17,157	-45,947	-52,903
Gain on equity investments	-	0	0	0
Change in fair value of equity investments	-13,487	46,999	9,691	4,579
Other income	2,663	3,131	3,623	5,438
Total other expense	-10,824	50,130	13,314	10,017
Gain before income taxes	-59,618	32,973	-32,633	-42,886
Income taxes (benefit) at statutory federal rate	-	-5,372*	-	-
State and local taxes, net of federal income tax effect	-	-12*	-	-
Foreign tax effects, other foreign	-	-98*	-	-
Other	-	38*	-	-
General business credits	-	3,186*	-	-
Changes in valuation allowance	-	7,931*	-	-
Equity compensation	-	589*	-	-
Section 162 officer's compensation	-	318*	-	-
Other	-	136*	-	-
Changes in unrecognized tax benefits	-	1,248*	-	-
Transfer pricing	-	-864*	-	-
Other, net	-	-265*	-	-
Income tax expense	408	462	162	287
Net gain	-60,026	32,511	-32,795	-43,173

Basic EPS	-0.81	0.441	-0.45	-0.59
Diluted EPS	-0.81	0.441	-0.45	-0.59
Basic Average Shares	73,989,137	73,674,551	73,613,090	73,427,635
Diluted Average Shares	73,989,137	73,674,551	73,613,090	73,427,635

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.